153 related articles for article (PubMed ID: 28650661)
1. Triaryl Benzimidazoles as a New Class of Antibacterial Agents against Resistant Pathogenic Microorganisms.
Picconi P; Hind C; Jamshidi S; Nahar K; Clifford M; Wand ME; Sutton JM; Rahman KM
J Med Chem; 2017 Jul; 60(14):6045-6059. PubMed ID: 28650661
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives.
El-Shershaby MH; El-Gamal KM; Bayoumi AH; El-Adl K; Ahmed HEA; Abulkhair HS
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000277. PubMed ID: 33078877
[TBL] [Abstract][Full Text] [Related]
3. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents.
Khan T; Sankhe K; Suvarna V; Sherje A; Patel K; Dravyakar B
Biomed Pharmacother; 2018 Jul; 103():923-938. PubMed ID: 29710509
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies.
Ammar YA; Farag AA; Ali AM; Hessein SA; Askar AA; Fayed EA; Elsisi DM; Ragab A
Bioorg Chem; 2020 Jun; 99():103841. PubMed ID: 32325335
[TBL] [Abstract][Full Text] [Related]
5. Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitors.
Cooper IR; McCarroll AJ; McGarry D; Kirkham J; Pichowicz M; Walker R; Warrilow C; Salisbury AM; Savage VJ; Moyo E; Forward H; Cheung J; Metzger R; Gault Z; Nelson G; Hughes D; Cao S; Maclean J; Charrier C; Craighead M; Best S; Stokes NR; Ratcliffe AJ
Bioorg Med Chem Lett; 2016 Sep; 26(17):4179-83. PubMed ID: 27499455
[TBL] [Abstract][Full Text] [Related]
6. Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2).
Singh SB; Kaelin DE; Wu J; Miesel L; Tan CM; Black T; Nargund R; Meinke PT; Olsen DB; Lagrutta A; Lu J; Patel S; Rickert KW; Smith RF; Soisson S; Sherer E; Joyce LA; Wei C; Peng X; Wang X; Fukuda H; Kishii R; Takei M; Takano H; Shibasaki M; Yajima M; Nishimura A; Shibata T; Fukuda Y
Bioorg Med Chem Lett; 2015 May; 25(9):1831-5. PubMed ID: 25851938
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of WO2012177707 and WO2012097269: Vertex's phosphate prodrugs of gyrase and topoisomerase antibacterial agents.
Finn J
Expert Opin Ther Pat; 2013 Sep; 23(9):1233-7. PubMed ID: 23924360
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antibacterial properties of pyrimido[4,5-b]indol-8-amine inhibitors of DNA gyrase.
McGarry DH; Cooper IR; Walker R; Warrilow CE; Pichowicz M; Ratcliffe AJ; Salisbury AM; Savage VJ; Moyo E; Maclean J; Smith A; Charrier C; Stokes NR; Lindsay DM; Kerr WJ
Bioorg Med Chem Lett; 2018 Sep; 28(17):2998-3003. PubMed ID: 30122228
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antibacterial activity of 5-halogenomethylsulfonyl- benzimidazole and benzotriazole derivatives.
Ochal Z; Bretner M; Wolinowska R; Tyski S
Med Chem; 2013 Dec; 9(8):1129-36. PubMed ID: 23339322
[TBL] [Abstract][Full Text] [Related]
10. C8-Linked Pyrrolobenzodiazepine Monomers with Inverted Building Blocks Show Selective Activity against Multidrug Resistant Gram-Positive Bacteria.
Andriollo P; Hind CK; Picconi P; Nahar KS; Jamshidi S; Varsha A; Clifford M; Sutton JM; Rahman KM
ACS Infect Dis; 2018 Feb; 4(2):158-174. PubMed ID: 29260545
[TBL] [Abstract][Full Text] [Related]
11. In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases.
Charrier C; Salisbury AM; Savage VJ; Moyo E; Forward H; Ooi N; Cheung J; Metzger R; McGarry D; Walker R; Cooper IR; Ratcliffe AJ; Stokes NR
J Antimicrob Chemother; 2016 Oct; 71(10):2831-9. PubMed ID: 27353465
[TBL] [Abstract][Full Text] [Related]
12. Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents.
Tari LW; Li X; Trzoss M; Bensen DC; Chen Z; Lam T; Zhang J; Lee SJ; Hough G; Phillipson D; Akers-Rodriguez S; Cunningham ML; Kwan BP; Nelson KJ; Castellano A; Locke JB; Brown-Driver V; Murphy TM; Ong VS; Pillar CM; Shinabarger DL; Nix J; Lightstone FC; Wong SE; Nguyen TB; Shaw KJ; Finn J
PLoS One; 2013; 8(12):e84409. PubMed ID: 24386374
[TBL] [Abstract][Full Text] [Related]
13. Second-generation 4,5,6,7-tetrahydrobenzo[
Lamut A; Skok Ž; Barančoková M; Gutierrez LJ; Cruz CD; Tammela P; Draskovits G; Szili PÉ; Nyerges Á; Pál C; Molek P; Bratkovič T; Ilaš J; Zidar N; Zega A; Enriz RD; Kikelj D; Tomašič T
Future Med Chem; 2020 Feb; 12(4):277-297. PubMed ID: 32043377
[No Abstract] [Full Text] [Related]
14. Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative Bacteria.
Gerasyuto AI; Arnold MA; Wang J; Chen G; Zhang X; Smith S; Woll MG; Baird J; Zhang N; Almstead NG; Narasimhan J; Peddi S; Dumble M; Sheedy J; Weetall M; Branstrom AA; Prasad JVN; Karp GM
J Med Chem; 2018 May; 61(10):4456-4475. PubMed ID: 29727185
[TBL] [Abstract][Full Text] [Related]
15. Symmetric bis-benzimidazoles are potent anti-staphylococcal agents with dual inhibitory mechanisms against DNA gyrase.
Dale AG; Hinds J; Mann J; Taylor PW; Neidle S
Biochemistry; 2012 Jul; 51(29):5860-71. PubMed ID: 22746203
[TBL] [Abstract][Full Text] [Related]
16. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
Tiz DB; Skok Ž; Durcik M; Tomašič T; Mašič LP; Ilaš J; Zega A; Draskovits G; Révész T; Nyerges Á; Pál C; Cruz CD; Tammela P; Žigon D; Kikelj D; Zidar N
Eur J Med Chem; 2019 Apr; 167():269-290. PubMed ID: 30776691
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Antimicrobial Evaluation and Molecular Docking of Some Potential 2,6-disubstituted 1H-Benzimidazoles; Non-Classical Antifolates.
Harer S; Bhatia M; Kawade V
Med Chem; 2019; 15(7):813-832. PubMed ID: 30727904
[TBL] [Abstract][Full Text] [Related]
18. Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective.
Ponnusamy T; Alagumuthu M; Thamaraiselvi S
Bioorg Med Chem; 2018 Jul; 26(12):3438-3452. PubMed ID: 29803359
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of head-to-head bis-benzimidazoles.
Moreira JB; Mann J; Neidle S; McHugh TD; Taylor PW
Int J Antimicrob Agents; 2013 Oct; 42(4):361-6. PubMed ID: 23837928
[TBL] [Abstract][Full Text] [Related]
20. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
